In all, our data demonstrate that vimentin, like VEGF, (i) reduces VE-cadherin expression, cell-cell interactions and vascular integrity, (ii) supports tumor angiogenesis, and (iii) hampers antitumor immunity. This evidence concerns the gene VEGFA and neoplasm.